AKT1 and metabolic dysfunction-associated steatohepatitis: More recently, a mouse model for non‐alcoholic steatohepatitis (NASH), a frequent liver disease in humans characterized by excessive fat build‐up in the liver, was generated using spCas9 to delete Pten, a tumour suppressor gene involved in NASH and a repressor of the PI3/AKT pathway.